Influenza Diagnostics Market by Test type (Molecular (RT-PCR,LAMP, NASBA), Traditional (Viral Culture, Direct Fluorescent Antibody, Rapid Influenza Detection Tests, Serological Assays)), End user (Hospital, Clinical Laboratories) - Global Forecast to 2025

Abstract
Apex Market Research has published a new report titled ”Global Influenza Diagnostics Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global Influenza Diagnostics market is estimated to grow from USD 695 billion in 2020 to USD 1012 billion by 2025, at a CAGR of 7.8%. The report offers in-depth insights, revenue details, and other vital information regarding the global Influenza Diagnostics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the Influenza Diagnostics market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global Influenza Diagnostics market report offers in-depth insights, revenue details, and other vital information regarding the global Influenza Diagnostics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of Influenza Diagnostics market. The major players operating into Influenza Diagnostics Market include: F. Hoffmann-La Roche AG (Switzerland)
Quidel Corporation (US)
Thermo Fisher Scientific (US)
Abbott Laboratories (US)
Hologic (US)
Becton
Dickinson
and Company (US)
DiaSorin S.p.A (Italy)
Luminex Corporation (US)
Meridian Bioscience (US)
GenMark Diagnostics (US)
SA Scientific (US)
Sekisui Diagnostics (US)
bioMrieux SA (France)
Danaher Corporation (US)
Siemens Healthineers (Germany)
Tecan Trading AG (Switzerland)
and ELITech (France)
Mast Group (England)
altona Diagnostics (Germany)
Coris BioConcept (Belgium)
Genome Diagnostics (India)
Germaine Laboratories (US)
Response Biomedical (Canada)
TAUNS Laboratories (Japan)
and TRUPCR (India) Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value Values (USD Million)
Covered Segments By Test Type, End-User, and Region
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the Influenza Diagnostics market to forecast revenues and analyze trends in each of the following submarkets:

Based on test type, the influenza diagnostic market is segmented as follows:

  • Traditional Diagnostic Tests
    • RIDT
    • Viral Culture
    • DFA
    • Serological assays
  • Molecular Diagnostic Tests
    • RT-PCR
    • INNAT
      • TMA
      • LAMP
      • NASBA
      • Other INNAT
    • Other Molecular Tests

Based on end-user, the influenza diagnostic market is segmented as follows:

  • Hospitals
  • Clinical Laboratories
  • Other End-User
By geography, this market has been segregated into five regions with revenue and growth rate of Influenza Diagnostics from 2020 to 2027,
There are 13 chapters to put on view for Influenza Diagnostics Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Influenza Diagnostics Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Influenza Diagnostics Market Overview 1.1.1 Influenza Diagnostics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Influenza Diagnostics Market Size and Analysis by Regions (2015-2019) 1.2.1 North America Influenza Diagnostics Market Status and Outlook 1.2.2 EU Influenza Diagnostics Market Status and Outlook 1.2.3 Japan Influenza Diagnostics Market Status and Outlook 1.2.4 China Influenza Diagnostics Market Status and Outlook 1.2.5 India Influenza Diagnostics Market Status and Outlook 1.2.6 Southeast Asia Influenza Diagnostics Market Status and Outlook 1.3 Global Influenza Diagnostics Market Segment Based on test type, the influenza diagnostic market is segmented as follows:
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.2 Traditional Diagnostic Tests
1.3.2.1 RIDT
1.3.2.2 Viral Culture
1.3.2.3 DFA
1.3.2.4 Serological assays
1.3.2.5 Market Estimates And Forecast By Country, 2015-2027
1.3.3 Molecular Diagnostic Tests
1.3.3.1 RT-PCR
1.3.4 INNAT
1.3.4.1 TMA
1.3.4.2 LAMP
1.3.4.3 NASBA
1.3.4.4 Other INNAT
1.3.4.5 Market Estimates And Forecast By Country, 2015-2027
1.3.4.4 Other Molecular Tests
1.3.4.5 Market Estimates And Forecast By Country, 2015-2027
1.4 Global Influenza Diagnostics Market Segment Based on end-user, the influenza diagnostic market is segmented as follows:
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.1 Hospitals
1.4.1.1 Market Estimates And Forecast By Country, 2015-2027
1.4.2 Clinical Laboratories
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Other End-User
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global Influenza Diagnostics Competition Analysis by Players 2.1 Global Influenza Diagnostics Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 F. Hoffmann-La Roche AG (Switzerland) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 F. Hoffmann-La Roche AG (Switzerland), Influenza Diagnostics Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Quidel Corporation (US) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Quidel Corporation (US), Influenza Diagnostics Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 Thermo Fisher Scientific (US) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Thermo Fisher Scientific (US), Influenza Diagnostics Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 Abbott Laboratories (US) 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Abbott Laboratories (US), Influenza Diagnostics Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 Hologic (US) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Hologic (US), Influenza Diagnostics Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 Becton 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Becton, Influenza Diagnostics Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Dickinson 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Dickinson, Influenza Diagnostics Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 and Company (US) 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 and Company (US), Influenza Diagnostics Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 DiaSorin S.p.A (Italy) 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 DiaSorin S.p.A (Italy), Influenza Diagnostics Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 Luminex Corporation (US) 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Luminex Corporation (US), Influenza Diagnostics Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global Influenza Diagnostics Market Size Type (2015-2019) 4.1 Global Influenza Diagnostics Market Size by Type (2015-2019) Chapter 5 Global Influenza Diagnostics Market Size Application (2015-2019) 5.1 Global Influenza Diagnostics Market Size by Application (2015-2019) 5.2 Potential Application of Influenza Diagnostics in Future 5.3 Top Consumer / End Users of Influenza Diagnostics Chapter 6 North America Influenza Diagnostics Development Status and Outlook 6.1 North America Influenza Diagnostics Market Size (2015-2019) 6.2 North America Influenza Diagnostics Market Size by Application (2015-2019) Chapter 7 EU Influenza Diagnostics Development Status and Outlook 7.1 EU Influenza Diagnostics Market Size (2015-2019) 7.2 EU Influenza Diagnostics Market Size by Application (2015-2019) Chapter 8 Japan Influenza Diagnostics Development Status and Outlook 8.1 Japan Influenza Diagnostics Market Size (2015-2019) 8.2 Japan Influenza Diagnostics Market Size by Application (2015-2019) Chapter 9 China Influenza Diagnostics Development Status and Outlook 9.1 China Influenza Diagnostics Market Size and Forecast (2015-2019) 9.2 China Influenza Diagnostics Market Size by Application (2015-2019) Chapter 10 India Influenza Diagnostics Development Status and Outlook 10.1 India Influenza Diagnostics Market Size and Forecast (2015-2019) 10.2 India Influenza Diagnostics Market Size by Application (2015-2019) Chapter 11 Southeast Asia Influenza Diagnostics Development Status and Outlook 11.1 Southeast Asia Influenza Diagnostics Market Size and Forecast (2015-2019) 11.2 Southeast Asia Influenza Diagnostics Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global Influenza Diagnostics Market Size (Million USD) by Regions (2020-2027) 12.1. North America Influenza Diagnostics Revenue and Growth Rate (2020-2027) 12.1.2 EU Influenza Diagnostics Revenue and Growth Rate (2020-2027) 12.1.3 China Influenza Diagnostics Revenue and Growth Rate (2020-2027) 12.1.4 Japan Influenza Diagnostics Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia Influenza Diagnostics Revenue and Growth Rate (2020-2027) 12.1.6 India Influenza Diagnostics Revenue and Growth Rate (2020-2027) 12.2 Global Influenza Diagnostics Market Size by Application (2020-2027) Chapter 13 Influenza Diagnostics Market Dynamics 13.1 Influenza Diagnostics Market Opportunities 13.2 Influenza Diagnostics Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Influenza Diagnostics Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Influenza Diagnostics Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
8221

3517

OUR CLIENT